Serological changes in patients with severe SLE treated with rituximab and cyclophosphamide.

被引：0
|
作者：
Jónsdóttir, Thórunn [1 ]
Gunnarsson, Iva [1 ]
Risselada, Anke [1 ]
Wallerskog, Therese [1 ]
Winqvist, Ola [1 ]
Wikström, Ann-Charlotte [1 ]
Klareskog, Lars [1 ]
van Vollenhoven, Ronald F. [1 ]
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S259 / S260
页数：2
相关论文
共 50 条
  • [21] DYNAMICS OF B LYMPHOCYTE SUBSETS IN SLE PATIENTS TREATED WITH RITUXIMAB
    Mesnyankina, A. A.
    Aleksandrova, E. N.
    Soloviev, S. K.
    Aleksankin, A. P.
    Glukhova, S. I.
    Novikov, A. A.
    Suponitskaya, E. V.
    Aseeva, E. A.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 289 - 289
  • [22] INTRAVENOUS CYCLOPHOSPHAMIDE THERAPY OF SEVERE SLE
    MCCUNE, WJ
    FOX, D
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1989, 15 (03) : 455 - 477
  • [23] Solid malignancies among Wegener's granulomatosis patients treated with etanercept: Potential interaction with cyclophosphamide.
    Stone, JH
    Holbrook, JT
    Marriott, MA
    Tibbs, AK
    Sejismundo, LP
    Min, YI
    Specks, U
    Merkel, PA
    Spiera, R
    Davis, JC
    St Clair, EW
    McCune, J
    Ytterberg, SR
    Allen, NB
    Hoffman, GS
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S272 - S273
  • [24] Integrating oncology and neurology nursing to care for myasthenia gravis patients treated with high dose cyclophosphamide.
    Barton, K
    Yee, H
    ONCOLOGY NURSING FORUM, 2005, 32 (02) : 468 - 468
  • [25] Wegener's granulomatosis, long time follow-up of patients treated with pulse cyclophosphamide.
    Koldingsnes, W
    Gran, JT
    Omdal, R
    Husby, G
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 809 - 809
  • [26] DYNAMICS OF B LYMPHOCYTE SUBSETS COUNTS IN SLE PATIENTS TREATED WITH RITUXIMAB
    Mesnyankina, A. A.
    Aleksandrova, E. N.
    Soloviev, S. K.
    Aleksankin, A. P.
    Gluhova, S. I.
    Novikov, A. A.
    Aseeva, E. A.
    Suponitskaya, E. V.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1073 - 1073
  • [27] Millimeter waves in vivo increase immune activity of mice treated with cyclophosphamide.
    Rojavin, MA
    Tsygankov, AY
    Ziskin, MC
    FASEB JOURNAL, 1997, 11 (03): : 2609 - 2609
  • [28] Severe infections in patients with autoimmune diseases treated with cyclophosphamide
    Cavallasca, Javier A.
    Costa, Cecilia A.
    del Rosario Maliandi, Maria
    Contini, Liliana E.
    Fernandez de Carrera, Elena
    Musuruana, Jorge L.
    REUMATOLOGIA CLINICA, 2015, 11 (04): : 221 - 223
  • [29] A 4-week course of rituximab plus cyclophosphamide in severe SLE: Promising results in 9 patients who failed conventional immunosuppressive therapy
    Van Vollenhoven, RF
    Gunnarsson, I
    Welin-Henriksson, E
    Sundelin, B
    Jacobson, SH
    Klareskog, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 112 - 113
  • [30] Cervical cancer and dysplasia in intravenous cyclophosphamide-treated patients with SLE.
    Bateman, H
    Yaziei, Y
    Leff, L
    Paget, S
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S107 - S107
12345